Banque Cantonale Vaudoise’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Buy
29,164
+7,209
+33% +$342K 0.04% 365
2025
Q4
$1.12M Buy
21,955
+1,971
+10% +$101K 0.04% 351
2025
Q3
$1.11M Buy
19,984
+1,168
+6% +$68.4K 0.04% 345
2025
Q2
$1.3M Buy
18,816
+4,241
+29% +$288K 0.05% 314
2025
Q1
$1.01M Buy
+14,575
New +$1.2M 0.04% 352
2024
Q3
$1.15M Sell
9,650
-173
-2% -$23.1K 0.05% 297
2024
Q2
$1.4M Sell
9,823
-444
-4% -$58.8K 0.06% 288
2024
Q1
$1.32M Buy
10,267
+9,603
+1,446% +$1.14M 0.05% 317
2023
Q4
$69K Hold
664
﹤0.01% 750
2023
Q3
$60K Sell
664
-726
-52% -$64K ﹤0.01% 941
2023
Q2
$113K Sell
1,390
-926
-40% -$75.6K 0.01% 838
2023
Q1
$184K Sell
2,316
-1,284
-36% -$91K 0.01% 719
2022
Q4
$243K Sell
3,600
-336
-9% -$19.7K 0.01% 661
2022
Q3
$197K Buy
3,936
+412
+12% +$22.1K 0.01% 725
2022
Q2
$197K Buy
3,524
+106
+3% +$5.88K 0.01% 741
2022
Q1
$189K Sell
3,418
-1,352
-28% -$69.4K 0.01% 801
2021
Q4
$267K Sell
4,770
-276
-5% -$15K 0.01% 759
2021
Q3
$242K Sell
5,046
-264
-5% -$12.8K 0.01% 751
2021
Q2
$222K Buy
+5,310
New +$206K 0.01% 821

Other funds holding NVO

Banque Cantonale Vaudoise's NVO Position: Q1 2026 in Review

Banque Cantonale Vaudoise increased its Novo Nordisk (NVO) stake by 33% in Q1 2026, buying an estimated $342K and bringing the position to 29,164 shares worth $1.07M. The position accounts for 0.04% of the portfolio, ranked #365.

Banque Cantonale Vaudoise first reported a position in NVO in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.4M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Banque Cantonale Vaudoise held 29,164 shares of Novo Nordisk worth $1.07M as of Q1 2026.
  • Banque Cantonale Vaudoise bought 7,209 Novo Nordisk shares in Q1 2026, an estimated $342K.
  • Novo Nordisk made up 0.04% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #365 holding.
  • Banque Cantonale Vaudoise first reported a position in Novo Nordisk in Q2 2021 and has held it in 19 quarters since.
  • Banque Cantonale Vaudoise's Novo Nordisk position peaked at $1.4M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.